Robert Wills is an accomplished leader in the biotechnology sector with extensive experience serving on the boards of various companies, including Alpha Cognition, Inc., Parion Sciences, GO Therapeutics, and Milestone Pharmaceuticals, Inc., where Wills held the position of Chairman of the Board. Formerly, Wills served as Chairman of the Board at CymaBay Therapeutics and Executive Chairman at GTx, Inc. Wills has contributed to the Biotechnology Innovation Organization and held a significant role at Johnson & Johnson as Vice President of Alliance Management. Wills holds a Doctor of Philosophy (Ph.D.) in Pharmacokinetics from The University of Texas at Austin and a Bachelor of Science (BS) in Biochemistry from the University of Wisconsin-Madison.
This person is not in the org chart
This person is not in any teams
This person is not in any offices